+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alexion Pharmaceuticals - logo

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion developed Soliris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is approved in more than 50 countries for PNH and more than 40 countries for aHUS. Alexion's company headquarters are based Cheshire, Connecticut, United States.

Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment - Global Strategic Business Report - Product Thumbnail Image

Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 93 Pages
  • Global
From
PharmSource - Bio/Pharma CapEx Trends - 2019 Edition - Product Thumbnail Image

PharmSource - Bio/Pharma CapEx Trends - 2019 Edition

  • Report
  • December 2019
  • 32 Pages
  • Global
From
Transthyretin (ATTR or Prealbumin or TBPA or TTR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Transthyretin (ATTR or Prealbumin or TBPA or TTR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 85 Pages
  • Global
From
Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 672 Pages
  • Global
From
Guillain-Barre Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Guillain-Barre Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 83 Pages
  • Global
From
Cough And Cold Preparations Global Market Opportunities And Strategies To 2032 - Product Thumbnail Image

Cough And Cold Preparations Global Market Opportunities And Strategies To 2032

  • Report
  • February 2023
  • 317 Pages
  • Global
From
Neuromyelitis Optica (Devic's Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Neuromyelitis Optica (Devic's Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 117 Pages
  • Global
From
Global Genome Editing Market, 2023-2035: Focus on Technology, Industry Trends and Forecasts - Product Thumbnail Image

Global Genome Editing Market, 2023-2035: Focus on Technology, Industry Trends and Forecasts

  • Report
  • January 2024
  • 270 Pages
  • Global
From
Alopecia - Pipeline Review, H2 2020 - Product Thumbnail Image

Alopecia - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 222 Pages
  • Global
From
Investor Series: Opportunities in RNA Therapeutics Market - Product Thumbnail Image

Investor Series: Opportunities in RNA Therapeutics Market

  • Report
  • March 2023
  • 174 Pages
  • Global
From
Chronic Kidney Disease Market: Pipeline Review, Developer Landscape and Competitive Insights - Product Thumbnail Image

Chronic Kidney Disease Market: Pipeline Review, Developer Landscape and Competitive Insights

  • Report
  • November 2018
  • 164 Pages
  • Global
From
DNA Encoded Library: Platforms and Services Market (2nd Edition), 2023-2035 - Product Thumbnail Image

DNA Encoded Library: Platforms and Services Market (2nd Edition), 2023-2035

  • Report
  • October 2023
  • 278 Pages
  • Global
From
Central Nervous System Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Central Nervous System Collaboration and Licensing Deals 2019-2024

  • Report
  • October 2024
  • 500 Pages
  • Global
From
Pharmerging - Global Strategic Business Report - Product Thumbnail Image

Pharmerging - Global Strategic Business Report

  • Report
  • November 2024
  • 184 Pages
  • Global
From
A Review of the Best Selling Pharmaceutical Drugs in 2021: 2023 Research Report - Product Thumbnail Image

A Review of the Best Selling Pharmaceutical Drugs in 2021: 2023 Research Report

  • Report
  • February 2023
  • 255 Pages
  • Global
From
North America Rare Disease Therapeutics Market, By Country, Competition, Forecast & Opportunities, 2019-2029F - Product Thumbnail Image

North America Rare Disease Therapeutics Market, By Country, Competition, Forecast & Opportunities, 2019-2029F

  • Report
  • August 2024
  • 133 Pages
  • North America
From
Genomic Collaboration and Licensing Deals 2018-2024 - Product Thumbnail Image

Genomic Collaboration and Licensing Deals 2018-2024

  • Report
  • November 2024
  • 350 Pages
  • Global
From
Acute Kidney Injury (AKI) - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Acute Kidney Injury (AKI) - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • January 2024
  • 179 Pages
  • Global
From
Rare Kidney Disease Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Rare Kidney Disease Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • December 2022
  • 120 Pages
  • Global
From
Enzyme Replacement Therapy Market by Therapeutic Condition, Enzyme Type, Route of Administration, End-User - Global Forecast 2025-2030 - Product Thumbnail Image

Enzyme Replacement Therapy Market by Therapeutic Condition, Enzyme Type, Route of Administration, End-User - Global Forecast 2025-2030

  • Report
  • October 2024
  • 181 Pages
  • Global
From
Loading Indicator